Nuvectis Pharma, Inc. (NASDAQ:NVCT)
| Market Cap | 520.38M+214.8% |
| Revenue (ttm) | 0 |
| Net Income | -27.85M-26.2% |
| EPS | -1.31-13.9% |
| Shares Out | 26.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 61,098.733 |
| Open | 20.37 |
| Previous Close | 20.29 |
| Day's Range | 19.59 - 20.37 |
| 52-Week Range | 5.55 - 29.28 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 37.33(+90.36%) |
| Earnings Date | Nov 3, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About NVCT
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$NVCT stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NVCT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NVCT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NVCT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NVCT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NVCT from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NVCT
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $14.79M |
| IWMiShares Russell 2000 ETF | $11.06M |
| VXFVanguard Extended Market ETF | $4.63M |
| IWOiShares Russell 2000 Growth ETF | $3.93M |
| VTWOVanguard Russell 2000 ETF | $2.23M |
| FESMFidelity Enhanced Small Cap ETF | $2.03M |
Estimated from each fund’s disclosed top holdings × AUM
NVCT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from NVCT’s recent data — informational, not investment advice